AlphaCore Capital’s Antares Pharma, Inc. ATRS Stock Holding History

AlphaCore Capital’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-23,621	Closed	-$97K	–	182
2022 Q1	$97K	Hold	23,621	–	–	0.04%	83
2021 Q4	$84K	Hold	23,621	–	–	0.04%	63
2021 Q3	$86K	Buy	+23,621	New	+$95.5K	0.04%	68

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AlphaCore Capital's ATRS Position: Q2 2022 in Review

AlphaCore Capital sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 23,621 shares — an estimated $97K sold.

AlphaCore Capital first reported a position in ATRS in Q3 2021 and held it in 3 quarters. The position peaked at $97K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

AlphaCore Capital reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
AlphaCore Capital sold 23,621 Antares Pharma, Inc. shares in Q2 2022, an estimated $97K.
AlphaCore Capital first reported a position in Antares Pharma, Inc. in Q3 2021 and held it in 3 quarters.
AlphaCore Capital's Antares Pharma, Inc. position peaked at $97K in Q1 2022.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on AlphaCore Capital's 13F filing for Q2 2022, filed 12 Aug 2022.